0001485003-19-000047.txt : 20190712
0001485003-19-000047.hdr.sgml : 20190712
20190712173150
ACCESSION NUMBER: 0001485003-19-000047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190710
FILED AS OF DATE: 20190712
DATE AS OF CHANGE: 20190712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MacDonald Glen C
CENTRAL INDEX KEY: 0001773277
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 19953667
MAIL ADDRESS:
STREET 1: 245 FIRST STREET, SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sesen Bio, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8550
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc.
DATE OF NAME CHANGE: 20100223
4
1
wf-form4_156296709613910.xml
FORM 4
X0306
4
2019-07-10
0
0001485003
Sesen Bio, Inc.
SESN
0001773277
MacDonald Glen C
C/O SESEN BIO, INC.
SUITE 1800
CAMBRIDGE
MA
02142
0
1
0
0
Chief Technology Officer
Employee Stock Option (Right to Buy)
1.59
2019-07-10
4
A
0
0
1.59
A
2027-10-03
Common Stock
24900.0
102780
D
On October 4, 2017, the reporting person was granted an option to purchase 120,000 shares of common stock. This option vests in installments based on the achievement of certain strategic and clinical milestones. On July 10, 2019, the Compensation Committee of the Board of Directors of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 24,900 shares.
/s/ Richard F. Fitzgerald
2019-07-12